5 blue chip ASX 200 shares to buy in October and hold for 10 years

Let's see why these shares could be great long term options according to analysts.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Analysts identify five ASX 200 blue-chip shares as top long-term picks due to their robust growth potential and strategic market positions.
  • These shares are involved in sectors such as gaming technology, biotechnology, property, and digital platforms, each capitalising on global trends.
  • The companies are expected to deliver sustained earnings growth, supported by strong balance sheets and strategic expansions.

The S&P/ASX 200 index has started the new quarter just shy of record highs.

But that doesn't mean there aren't any blue-chip opportunities out there for investors.

For example, five ASX 200 blue chip shares that analysts think are in the buy zone in October are listed below. Here's why they could be top long-term picks:

Two smiling work colleagues discuss an investment at their office.

Image source: Getty Images

Aristocrat Leisure Ltd (ASX: ALL)

Gaming technology powerhouse Aristocrat Leisure has expanded successfully beyond poker machines in recent years. For example, its acquisition of NeoGames has boosted exposure to the fast-growing real money gaming and online lottery sector. With strong earnings growth expected and resilient cash flow generation, Aristocrat remains a very attractive ASX 200 blue chip share.

Bell Potter is a fan and has a buy rating and $79.00 price target on its shares.

Cochlear Ltd (ASX: COH)

Hearing implant leader Cochlear could be a great buy and hold option. Demand for its devices is rising on the back of ageing populations across the globe and broader access to hearing healthcare. With a robust balance sheet and a track record of delivering both growth and dividends, Cochlear continues to earn its place as a reliable blue-chip holding.

UBS currently rates Cochlear as a buy with a $350.00 price target.

CSL Ltd (ASX: CSL)

Biotech leader CSL has faced pressure in recent months, with investor sentiment hit by the planned spin-off of Seqirus and potential US tariffs on pharmaceutical products. Even so, major brokers remain upbeat, with price targets significantly higher than current levels. And with plasma demand growing, new therapies in the pipeline, and a heavy investment in US manufacturing to reduce risk, CSL continues to stand out as a core long-term holding. Especially while it trades near a 52-week low.

Morgans currently has a buy rating and $293.83 price target on its shares.

Goodman Group (ASX: GMG)

Property giant Goodman Group has capitalised on surging demand for logistics and data centre space. With e-commerce, cloud computing, and AI infrastructure all requiring new developments, Goodman's global pipeline positions it at the heart of these megatrends. Backed by a strong balance sheet and disciplined capital management, this ASX 200 blue chip share looks well-placed to deliver sustained growth over the next decade.

Bell Potter is bullish and has a buy rating and $40.80 price target on its shares.

REA Group Ltd (ASX: REA)

Finally, REA Group has cemented itself as the go-to digital property platform in Australia. Pricing power, growth in adjacent services, and expansion offshore have helped it sustain double-digit earnings growth. And with the housing market expected to boom as interest rates fall, the coming years look likely to be very positive.

Bell Potter is also bullish on this one. It has a buy rating and $284.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL, Cochlear, Goodman Group, and REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, and Goodman Group. The Motley Fool Australia has recommended CSL, Cochlear, and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses offer compelling passive income.

Read more »

A young woman looks happily at her phone in one hand with a selection of retail shopping bags in her other hand.
Blue Chip Shares

If I invest $10,000 in Wesfarmers shares, how much passive income will I get in FY27?

The conglomerate has a long history of paying dividends to shareholders every six months.

Read more »

Woman with her kitten on a laptop in her home office.
Blue Chip Shares

Buy, hold, sell: Coles, Woodside & Telstra shares

Find out what the experts tip for these three well-known ASX shares.

Read more »

Person holding a blue chip.
Blue Chip Shares

2 ASX blue-chip shares experts rate as compelling

These businesses have a compelling outlook according to fund managers…

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses can deliver investors pleasing passive income.

Read more »

Stressed shopper holding shopping bags.
Retail Shares

Should I invest $6,000 in Wesfarmers shares in August?

Here's what brokers tip for the retail conglomerate’s shares now.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

Down 31%: Is it time to buy this popular ASX 200 blue chip?

Is it time to be bullish or bearish on this fallen giant? Here's what analysts are saying.

Read more »

A man surrounded by huge piles of paper looks through a magnifying glass at his computer screen.
Blue Chip Shares

Buy, hold, sell: Telstra, BHP, CSL shares

At the time of writing, brokers tip some element of upside from each of these ASX shares. Find out more…

Read more »